Skip to content

Clinical trials

Cardiovascular Diseases trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Not applicable Country / region: France Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20072
20082
20091
20104
20112
20125
20131
20142
20157
20166
20173
20184
20195
202010
20212
20232
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Active, not recruiting10
Recruiting7
Unknown status5
Terminated4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Edwards Lifesciences5
Hospices Civils de Lyon4
Abbott Medical Devices3
Assistance Publique Hopitaux De Marseille3
Unilever R&D3
University Hospital, Clermont-Ferrand3
Boston Scientific Corporation2
Central Hospital, Nancy, France2
Centre hospitalier de l'Université de Montréal (CHUM)2
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases68
Heart Diseases17
Heart Valve Diseases12
Vascular Diseases9
Aortic Valve Stenosis6
Heart Failure6
Hypertension5
Mitral Valve Insufficiency5
Atrial Fibrillation4
Coronary Artery Disease4

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.